Zevra Therapeutics(DE:1GDA)
€10.550.00 (0.00%)
DE:1GDA
Zevra Therapeutics earnings date
€10.55
At close:0.00 (0.00%)
Zevra Therapeutics (1GDA) Q2 2026 Earnings Report
1 Followers
DE:1GDA Q2 2026 EPS Results
- Actual EPS
- EUR 0.13
- Consensus EPS
- EUR 0.10
- Beat/Miss
- Beat by +EUR 0.03
- One Year Ago EPS
- EUR 1.09
DE:1GDA Q2 2026 Revenue Results
- Actual Revenue
- EUR 35.85M
- Expected Revenue
- EUR 30.63M
- Beat/Miss
- Beat by +EUR 5.22M
- YoY Revenue Growth
- +53.25%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/05/2026
- Time
- After Close
- Conference Call
- Wednesday, August 5, 2026
DE:1GDA Upcoming Earnings
Zevra Therapeutics's next earnings date is estimated for March 10, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:1GDA Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:1GDA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 10, 2027 | 2026 (Q4) | 0.17- | 0.17 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | 0.140.24 | -0.01 | 2700.00% (+0.24) | |
| Aug 05, 2026 | 2026 (Q2) | 0.100.13 | 1.09 | -88.43% (-0.97) | |
| May 06, 2026 | 2026 (Q1) | 0.070.54 | -0.05 | 1100.00% (+0.60) | |
| Mar 09, 2026 | 2025 (Q4) | 0.050.17 | -0.61 | 128.36% (+0.78) | |
| Nov 05, 2025 | 2025 (Q3) | -0.03-0.01 | -0.62 | 98.55% (+0.61) | |
| Aug 12, 2025 | 2025 (Q2) | 2.051.09 | -0.43 | 352.08% (+1.53) | |
| May 13, 2025 | 2025 (Q1) | -0.16-0.05 | -0.36 | 85.00% (+0.31) | |
| Mar 11, 2025 | 2024 (Q4) | -0.36-0.61 | -0.46 | -31.37% (-0.14) | |
| Nov 12, 2024 | 2024 (Q3) | -0.37-0.62 | -0.36 | -72.50% (-0.26) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
